Working together as a family and being a support system to a family member who is facing cancer due to asbestos exposure is one of the most meaningful things you can do. It’s not just about helping them physically but being an emotional and spiritual crutch that they can lean on in trying times. As […]
The post How Families Can Support Veterans Facing Cancer After Asbestos Exposure appeared first on Medical News Bulletin.
A mesothelioma diagnosis often arrives after months of breathing problems, chest pain, fatigue or repeated scans that never fully explained your symptoms. For many patients, the first few weeks feel overwhelming because appointments suddenly become filled with unfamiliar medical terms, treatment discussions and difficult decisions. Mesothelioma remains rare, but it is still strongly connected to […]
The post What patients should know after a mesothelioma diagnosis: Medical, emotional and practical next steps appeared first on Medical News Bulletin.
Scientists say that mosquitoes are figuring out that where there’s DEET, there’s meat.
The post Mosquitoes might know there’s a human under the smell of DEET appeared first on Medical News Bulletin.
CHICAGO — The bispecific antibody linvoseltamab exhibited rapid clinical activity among patients with relapsed or refractory systemic light chain amyloidosis, according to phase 1/phase 2 trial results presented at ASCO Annual Meeting.
All 20 treated patients achieved objective response and 18 achieved hematologic complete response.
Linvoseltamab (Lynozyfic, Regeneron) also exhibited what researchers characterized as a manageable safety profile, with no dose-limiting toxicities reported.
“The safety profile is very encouraging, and to see rapid and deep hematologic responses is unprecedented in
KIAWAH ISLAND, S.C. — Implanting an iStent in combination with phacoemulsification helped reduce IOP in patients with low-tension glaucoma, according to a study presented at Kiawah Eye and Retina.
Cody Manzanero, MD, said he and colleagues wanted to bridge the knowledge gap in an area that mostly looks at patients with open-angle glaucoma.
“There’s a plethora of data on primary open-angle glaucoma and iStent use in that disease,” he said. “But there’s not good long-term evidence of the use of iStent in normal-tension glaucoma, the longest study being 12 months.”
Manzanero and colleagues
The Infectious Diseases in Children Symposium has been endorsed by the Pediatric Infectious Diseases Society, according to a press release from Healio LIVE.
“The endorsement from PIDS reinforces the longstanding impact and credibility of IDC New York within the pediatric infectious diseases community,” Robert A. Esgro, chief operating officer of Vindico Medical Education and Healio LIVE, said. “By bringing together leading experts, frontline clinicians and a globally respected organization like PIDS, we are elevating the meeting experience and delivering even greater value to attendees,
Joel M. Gelfand, MD, MSCE, FAAD, is Chief Medical Editor of Healio Dermatology and the James J. Leyden Professor of Dermatology and Epidemiology at the Perelman School of Medicine at the University of Pennsylvania.
He is also director of the Center for Clinical Sciences in Dermatology and director of the Psoriasis and Phototherapy Treatment Center at Penn Medicine.
Gelfand also leads Healio’s Beneath the Surface video series, which features interviews with experts in the field about important topics in dermatology.
“I am delighted to work with Healio Dermatology and the outstanding experts on
Adewole “Ade” S. Adamson, MD, MPP, is a dermatologist, health services researcher and associate professor at Dell Medical School at the University of Texas at Austin.
“My work focuses on improving the quality, value and equity of melanoma and dermatologic care, with particular interest in cancer survivorship, screening and disparities. I am inspired by the opportunity to generate evidence that improves patient care while helping build a more just and effective health care system,” Adamson told Healio.
See Adamson’s Healio Dermatology Peer Perspective Board member contributions here.
Macrene Alexiades, MD, PhD, is associate clinical professor at Yale University School of Medicine and director and founder of the Dermatology & Laser Surgery Center of New York.
Alexiades is an attending physician at the Veterans Administration Yale-West New Haven VA Hospital, Yale New Haven Hospital and Northwell Health; an adjunct professor at Sigrou Hospital in Athens, Greece; and CEO and founder of Macrene actives.
Alexiades is an internationally recognized dermatologist and scientist who specializes in laser surgery and injectables.
See Alexiades’ Healio Dermatology Peer Perspective
Jerry Bagel, MD, MS, is clinical professor of dermatology at Icahn School of Medicine at Mount Sinai.
Bagel specializes in treating psoriasis and atopic dermatitis.
See Bagel’s Healio Dermatology Peer Perspective Board member contributions here.